 |
|
|
| |
Distribution and Antiviral Activity in Cerebrospinal Fluid (CSF) of the Integrase Inhibitor, Dolutegravir (DTG): ING116070 Week 16 Results
|
| |
| |
Reported by Jules Levin
CROI 2013 Atlanta Mar 3-6
Scott Letendre,1 Anthony Mills,2 Karen Tashima,3 Deborah Thomas,4 Sherene Min,4 Shuguang Chen,4 Ivy Song,4 Stephen Piscitelli,4 on behalf of the extended ING116070 study team
1UCSD Antiviral Research Center, San Diego, CA, USA; 2Anthony Mills MD, Inc, Los Angeles, CA, USA; 3The Miriam Hospital, Providence, RI, USA; 4GlaxoSmithKline, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
